Roadmap

Very.Insure Roadmap in 2023

Q1 2023:

Conduct market research and user testing to identify the specific needs of the target audience and improve the user experience.

Hire additional developers and engineers to enhance the platform's capabilities and improve security.

Collaborate with hospitals, medical professionals, and insurers to establish partnerships and test the platform's functionality.

Q2 2023:

Launch a beta version of the platform with limited functionalities to test and receive feedback from early adopters.

Improve the user interface and add more features, such as decentralized storage, smart contract management, and real-time data analytics.

Conduct additional testing to ensure the platform is secure, efficient, and user-friendly.

Q3 2023:

Launch the full version of the platform, including all features and functionalities.

Expand the platform's reach by collaborating with more hospitals, medical professionals, and insurers to increase the number of covered patients.

Enhance the platform's security and privacy by implementing additional security measures such as two-factor authentication and multi-signature wallets.

Q4 2023:

Conduct a thorough security audit to ensure the platform's security measures are up to industry standards.

Enhance the platform's marketing efforts to increase awareness and reach a larger audience.

Plan for future developments, such as integrating with other blockchain platforms and expanding to other regions.

Conclusion:

The 2023 roadmap for Very.Insure includes expanding the platform's functionalities and improving the user experience while maintaining a strong focus on security and privacy. The platform's collaboration with hospitals, medical professionals, and insurers will ensure its reach and provide a transparent pricing system that benefits patients and insurance providers. Overall, the roadmap will ensure that Very.Insure becomes a market leader in the decentralized insurance industry, providing a secure, efficient, and cost-effective solution for patients and insurers alike.